CTRI/2021/12/038569招募中1 期
EVALUATING CLINICAL EFFICACY OF VIRECHAN AND RASAYAN THERAPY (GO-MUTRA HARITAKI) IN THE MANAGEMENT OF HRUDROGA (CORONARY ARTERY DISEASES)- A RANDOMIZED CONTROL CLINICAL TRIA
试验速览
- 阶段
- 1 期
- 状态
- 招募中
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Both sex
- •2. Age group between 20-70 years
- •3. Class I, II&IIa (III) as per Canadian Cardiovascular Society grading of angina pectoris
- •4.CAC Scoring < 400/ <90 percentile
- •5. ECG- T wave inverted without Q wave / ST elevation
- •6.Stress TMT- Positive
- •7. Angiography- <60% occlusion in any of the coronary artery
- •8. Those are able to give written consent
排除标准
- •1.Renal insufficiency (S. Creatinine > 2 mg/dl, Blood Urea > 40 mg/dl)
- •2.â?•2D ECHO showing the presence of any valvular heart disease
- •3.Tachycardia( >160/min)/ Ventricular arrhythmia
- •4. Low Left Ventricular Ejection Fraction (LVEF < 40%)
- •4.â?•Positive Troponin Test
- •5.CT Angiography lesion > 60%
- •6.â?•CPK-MB > 5%
- •7. Prolonged or traumatic cardiovascular resuscitation
- •8. Previous Coronary Intervention (within 3 months) or any bypass surgery
- •9. Ischemic Cerebral stroke within past one months
- •10. Peripheral arterial diseases
- •11. Recent Head trauma or known intracranial neoplasm
- •12. Suspected aortic dissection
- •13. Prolonged chest pain ( > 30mints) associated with vomiting and syncope
- •14. Chest pain with vagotonia (bradycardia, pallor, and syncope)
- •15. Haemorrhagic stroke within past one month
- •16. Diabetic haemorrhagic retinopathy or other haemorrhagicopthalamic conditions.
- •17. Recorded uncontrolled Blood Pressure >180/100mmHg in three consecutive readings
- •18. Active peptic ulcer
- •19. Significant liver dysfunction
- •20.â?•Raised Prothrombin time, Activated Partial Thromboplastin Time
- •21.â?•Heart failure (Brain Natriuretic Peptide > 2 times)
- •22. Active bleeding, Known bleeding diathesis or current use of anticoagulant
- •23. BMI <18
- •24. All VirechanAnarha patients as mentioned in Ch. Si 2/11 will be excluded
- •VirechanAnarha are Subhag, Kshatgud, Muktanal, Adhog Raktapitta, Vilanghit,Durbal, Alpagni, Adivya nirudhaka, Ajirna, Nawajwar, Madatyay, Aadhman, Shalyadrit, Atisnigdha, Atiruksha, Krurkoshtha, Urahkshat, Kshina, Atisthul, Atikrusha, Garbhini.
- •Any other case if investigator feels could not include in the study during the course of study
- •(â?• Investigation will be done if feasible)
研究者
相似试验
尚未招募
3 期
Management of Liver Cancer in Ayurveda With Therapeutic Purgation and Rectal administration with Ayurvedic Drugs.CTRI/2021/09/036106Dr Sarvepalli Radhakrishnan Rajasthan Ayurved University Jodhpur
已完成
2 期
The effect of virechan and rasnasaptak kwath in the management of Amavata.CTRI/2021/09/036858Government Ayurvedic College Patna36
招募中
不适用
Management of obesityCTRI/2019/02/017379uttrakhand ayurveda university harrawala dehradun
尚未招募
2 期
AYURVEDIC MANAGEMENT FOR SHEETAPITTA (URTICARIA)CTRI/2021/03/031915Shree Jagadguru gavisidheswara ayurvedic medical college postgraduate studies and research centre
招募中
1 期
Ayurvedic Management in UrticariaCTRI/2022/09/045654Dr BRKR Govt Ayurvedic medical college